Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1918)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 27, 2023 (publication date) through May 13, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Purwar S, Fatima A, Bhattacharyya H, Simhachalam Kutikuppala LV, Cozma MA, Srichawla BS, Komer L, Nurani KM, Găman MA. Toxicity of targeted anticancer treatments on the liver in myeloproliferative neoplasms. World J Hepatol 2023; 15(9): 1021-1032 [PMID: 37900211 DOI: 10.4254/wjh.v15.i9.1021] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v15/i9/1021.htm |
| Number | Citing Articles |
| 1 |
Adeniyi Abraham Adesola, Matei-Alexandru Cozma, Yong-Feng Chen, Bahadar Singh Srichawla, Mihnea-Alexandru Găman. Risk of hepatitis B reactivation in patients with myeloproliferative neoplasms treated with ruxolitinib. World Journal of Hepatology 2023; 15(11): 1188-1195 doi: 10.4254/wjh.v15.i11.1188
Abstract(253) |
Core Tip(196) |
Full Article(HTML)(1095)
|
Full Article with Cover (PDF)-1278K(45)
|
Full Article (Word)-185K(25)
|
Audio-1002K(4)
|
Peer-Review Report-190K(27)
|
Answering Reviewers-264K(24)
|
Full Article (PDF)-482K(79)
|
Full Article (XML)-81K(38)
|
Times Cited (0)
|
Total Visits (2891)
|
Open
|